RT Journal Article
SR Electronic
T1 Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South Africa
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.01.08.20016972
DO 10.1101/2020.01.08.20016972
A1 Louise O Downs
A1 Sabeehah Vawda
A1 Phillip Armand Bester
A1 Katrina A Lythgoe
A1 Tingyan Wang
A1 Anna L McNaughton
A1 David A Smith
A1 Tongai Maponga
A1 Oliver Freeman
A1 Kinga A Várnai
A1 Jim Davies
A1 Kerrie Woods
A1 Christophe Fraser
A1 Eleanor Barnes
A1 Dominique Goedhals
A1 Philippa C Matthews
YR 2020
UL http://medrxiv.org/content/early/2020/02/07/2020.01.08.20016972.abstract
AB Hepatitis B virus (HBV) DNA viral loads (VL) show wide variation between individuals with chronic hepatitis B (CHB) infection, and are used to determine treatment eligibility. There are few refined descriptions of VL distribution in CHB, and limited understanding of the biology that underpins these patterns. We set out to describe the VL distribution in independent cohorts from the UK and South Africa, to identify associated host characteristics, and to compare with VL in HIV-1 and hepatitis C (HCV) infection. We show the presence of a set-point in chronic HBV infection and report significant differences in the viral load distribution of HBV when compared to HIV and HCV.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPCM is funded by the Wellcome Trust (ref 110110). KAL is funded by the Wellcome Trust and the The Royal Society (ref 107652/Z/15/Z). LOD is funded by the NIHR.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSuppl Fig 1 and full metadata for our study cohorts are available on-line at figshare. https://doi.org/10.6084/m9.figshare.11365082